ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

143 hedge funds and large institutions have $571M invested in Array Biopharma Inc in 2013 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

16% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 50

83% less call options, than puts

Call options by funds: $771K | Put options by funds: $4.48M

Holders
143
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$771K
Puts
$4.48M
Net Calls
Net Calls Change

Top Buyers

1 +$40M
2 +$12.6M
3 +$3.96M
4
DM
Deerfield Management
New York
+$3.26M
5
PA
Pinnacle Associates
New York
+$3.1M

Top Sellers

1 -$10.9M
2 -$9.06M
3 -$8.39M
4
PA
Perceptive Advisors
New York
-$3.56M
5
PI
Putnam Investments
Massachusetts
-$3.44M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$326K
77
$318K
78
$312K
79
$301K
80
$301K
81
$300K
82
$264K
83
$261K
84
$260K
85
$255K
86
$251K
87
$246K
88
$227K
89
$201K
90
$194K
91
$194K
92
$192K
93
$190K
94
$183K
95
$159K
96
$159K
97
$157K
98
$132K
99
$129K
100
$127K